Representatives of Spectrum Pharmaceuticals, Inc will brief NRC staff on its views regarding modification of the training and experience requirements for beta emitter products. Spectrum Pharmaceuticals recently submitted comments to the NRC on a proposed

Purpose

Representatives of Spectrum Pharmaceuticals, Inc will brief NRC staff on its views regarding modification of the training and experience requirements for beta emitter products. Spectrum Pharmaceuticals recently submitted comments to the NRC on a proposed rulemaking related to this topic. The proposed rule and the comments submitted by Spectrum Pharmaceuticals, Inc can be found at www.regulations.gov under NRC Docket ID NRC-2008-0175.

Meeting Feedback

Meeting Feedback Form

Meeting Dates and Times

02/12/15, 2PM - 3PM EST

Meeting Location

NRC Three White Flint North

11601 Landsdown Street
Rockville, MD

Webinar

Webinar Link:

Contact

James Danna

(301) 415-7422

Participation Level

Category 2

NRC Participants

Office of Nuclear Material Safety and Safeguards

Office of General Counsel

External Participants

Donna-Beth Howe

Edward Lohr

Esther Houseman

James Danna

Michael Fuller

Neelam Bhalla

Sandra Gabriel

Public Meeting Schedule: Meeting Details